2019年11月4日·無錫·國際生物醫(yī)藥論壇暨第九屆Cell Death & Disease國際研討會(huì)-新藥研發(fā)
重磅日程出爐，30位國際大咖共促生物醫(yī)藥產(chǎn)業(yè)發(fā)展—2019無錫國際生物醫(yī)藥論壇暨第九屆Cell Death & Disease國際研討會(huì)-新藥研發(fā)。
本次學(xué)術(shù)大會(huì)以無錫華泰創(chuàng)新藥研究院為國際科技合作與學(xué)術(shù)交流平臺(tái)，邀請(qǐng)生物醫(yī)藥領(lǐng)域最具國際影響力的世界頂尖科學(xué)家、領(lǐng)域發(fā)展前沿的先驅(qū)者，圍繞腫瘤細(xì)胞免疫、小分子靶向藥物、單克隆抗體藥物、細(xì)胞藥物與細(xì)胞治療研究與發(fā)展、理論與實(shí)踐、技術(shù)與策略等進(jìn)行大會(huì)學(xué)術(shù)交流，以助力我國生物醫(yī)藥研發(fā)創(chuàng)新與產(chǎn)業(yè)發(fā)展。這次學(xué)術(shù)大會(huì)是國際生物醫(yī)藥領(lǐng)域的一場(chǎng)科學(xué)盛宴，是面向高校、科研院所、醫(yī)療機(jī)構(gòu)和生物醫(yī)藥企業(yè)創(chuàng)新發(fā)展需求，極具啟發(fā)、引導(dǎo)作用的一次頭腦風(fēng)暴。本次大會(huì)還特別邀請(qǐng)了Springer Nature旗下的Cell Death & Disease雜志社主編赴會(huì)與參會(huì)人員交流，并作“How to Get Published”專題報(bào)告，以滿足科研人員論文發(fā)表的需要。
特邀嘉賓
會(huì)議議題：
議題一：免疫調(diào)節(jié)與炎癥性疾病
議題二：DNA損傷與癌癥和衰老
議題三：癌癥免疫治療
議題四：間充質(zhì)干細(xì)胞及其應(yīng)用
議題五：細(xì)胞死亡與自噬
議題六：藥物研發(fā)新策略
議題七：知識(shí)產(chǎn)權(quán)保護(hù)與申請(qǐng)
議題八：如何發(fā)表高水平研究論文
最新日程：
| Programme of The Wuxi International Bioforum 2019 and The 9th Cell Death & Disease Symposium – New Drug Discovery |
|||
| November 4-6, 2019 Wuxi, Jiangsu, China |
|||
| Sunday 3rd November | |||
| 10:00 – 19:00 | Registration | ||
| Monday 4th November | |||
| 10:00 – 12:50 | Registration | ||
| 12:50 – 13:00 | Welcome Address by Gerry Melino | ||
| Session I: Immunoregulation and Inflammatory Diseases 13:00-14:30 | |||
| Chair: Tak Wah Mak | |||
| 13:00 – 13:30 | TBA | Michel Sadelain | Memorial Sloan Kettering, USA |
| 13:30 – 14:00 | Targeting RAS in Cancer | Ruibao Ren | Shanghai Jiao-Tong University, China |
| 14:00 – 14:30 | Coffee Break | ||
| Session II: DNA Damage Response in Cancer and Aging 14:30-17:00 | |||
| Chair: Francesco Dazzi | |||
| 14:30 – 15:00 | ZNF281 Contributes to the DNA Damage Response and is A Prognostic Maker for Neuroblastoma | Gerry Melino | University of Rome-Tor Vergata, Italy |
| 15:00 – 15:30 | Inherited Cancers, Normal and Accelerated Aging: the Role of POLD1 Gene in Nuclear Shape and DNA Damage Repair | Giuseppe Novelli | University of Rome-Tor Vergata, Italy |
| 15:30 – 16:00 | TBA | Eike-Christin von Leitner or Susanne Arbogast, Indivumed | Germany |
| 16:00 – 16:30 | Aging-induced IL27Rα Signaling Impairs Hematopoietic Stem Cells | Jianwei Wang | Tsinghua University, China |
| 16:30 – 17:00 | TBA | Changshun Shao | Soochow University, China |
| 17:30 | Welcome Reception in Wuxi (Banquet) | ||
| Tuesday 5th November | |||
| 08:00 – 09:00 | Opening Ceremony for Wuxi Sinotide New Drug Discovery Institutes Welcome remarks by Chairmen and Distinguished Guests |
||
| Session III: Neuro Immunology 9:00-10:00 | |||
| Chair: Chen Dong | |||
| 09:00 – 09:30 | TBA | Tak Wah Mak | University of Toronto, Canada |
| 09:30 – 10:00 | The Diverse Roles of Matrix Metalloproteinase (MMP)-2 and MMP-9 in the Induction and Progression of Neuroinflammation | Lydia Sorokin | University of Münster, Germany |
| 10:00 – 10:30 | Coffee Break | ||
| Session IV: Novel Approaches to Critical Diseases 10:30-12:30 | |||
| Chair: Yong-Guang Yang | |||
| 10:30 – 11:00 | Novel Affinity-matured Peptide-exchangeable Peptide/HLA Multimers Enable Robust and Rigorous Identification of Antigen-Specific T cells | Naoto Hirano | University of Toronto, Canada |
| 11:00 – 11:30 | Emerging Techniques to Identify Antigenic Targets for the Treatment of Solid Tumors | Hans-Peter Gerber | 3T Biosciences, USA |
| 11:30 – 12:00 | Role of CD47-SIRPα Signaling in Transplantation and Cancer Immunology | Yong-Guang Yang | Jilin University, China |
| 12:00 – 12:30 | TBA | Chen Dong | Tsinghua University, China |
| 12:30 | Lunch | ||
| Session V: Novel Models for Future Theraputics 14:00-15:30 | |||
| Chair: Willem Fibbe | |||
| 14:00 – 14:30 | Fallen Angels: Mechanisms of T Cell Lymphoma | Jürgen Ruland | Techincal University Munich, Germany |
| 14:30 – 15:00 | CRISPR Gene Regulation and Biomedical Application | Min Wu | University of North Dakota, USA |
| 15:00 – 15:30 | The Robust Oncolytic Adenoviral Therapeutics Against the Majority of Type of Cancer, Targeted by A Smart Synthetic Tumor Specific Promoter | Jingde Zhu | The First Affiliated Hospital of USTC, China |
| 15:30-16:00 | Coffee Break | ||
| Session VI: Cell Death and Autophagy 16:00-17:00 | |||
| Chair: Yong-Jun Liu | |||
| 16:00 – 16:30 | Transglutaminase Type 2 in the Regulation of Proteostasis | Mauro Piacentini | University of Rome-Tor Vergata, Italy |
| 16:30 – 17:00 | The p63 C-terminus is Essential for Ovary Development | Eleonora Candi | University of Rome-Tor Vergata,Italy |
| 17:30 | Dinner | ||
| Wendesday 6 th November | |||
| Session VII: How to Get Publish in NPG and Apply Patent 7:00-9:00 | |||
| Chair: Yufang Shi | |||
| 07:00 – 07:30 | How to Write a Scientific Paper | Gerry Melino | University of Rome-Tor Vergata,Italy |
| 07:30 – 08:00 | How to Get Published | Rebecca Shreeve | Springer Nature, UK |
| 08:00 – 08:20 | TBA | Xun Xu | Xu & Partents LLC, China |
| 08:20 – 08:40 | ?TBA | Zhixin He | Zhixin & Partners Law FirmLimited, China |
| 08:40 – 09:00 | Patent Protection for Cell and Immunotherapy | Michael X. Ye | MORRIS, MANNING & MARTIN, LLP, USA |
| Session VIII: New Drug Discovery 9:00-10:30 | |||
| Chair: Giuseppe Novelli | |||
| 09:00 – 09:30 | Reimagining Druggability Using Chemoproteomic Platforms | Daniel Nomura | University of California, USA |
| 09:30 – 10:00 | Drug Discovery from Natural Products Library and Traditional Chinese Medicine | Qinshi Zhao | CAS, China |
| 10:00 – 10:30 | Translating Human Immunobiology to Medicine | Yong-Jun Liu | Sanofi, UK |
| 10:30 – 11:00 | Coffee Break | ||
| Session IX: Mesenchymal Stem Cells and Their Applications 11:00-13:00 | |||
| Chair: Lydia Sorokin | |||
| 11:00 – 11:30 | TBA | Yufang Shi | Soochow University, China |
| 11:30 – 12:00 | Mesenchymal Stromal Cells, Death and Disease | Francesco Dazzi | King’s College London, UK |
| 12:00 – 12:30 | A Mechanistic Approach to Mesenchymal Stromal Cell Therapy | Willem Fibbe | Leiden University, Netherland |
| 12:30 – 13:00 | Switching Macrophage: A Novel Therapeutic Strategy for Autoimmune Diseases | Ying Wang | CAS, China |
??
注冊(cè)報(bào)名
| 票價(jià)類型 | 學(xué)生票 | 科研院所票 | 企業(yè)票 |
| 單價(jià) | 500元/人 | 1000元/人 | 2000元/人 |
| 注意事項(xiàng) | 包含會(huì)議資料、午餐、茶歇等，不含住宿及晚餐。 | ||
會(huì)議官網(wǎng)：
大會(huì)聯(lián)系人：
尚倩雯
0510-83592811
無錫華泰創(chuàng)新藥技術(shù)研究院有限公司
無錫市惠山區(qū)惠山大道1699號(hào)生命科技產(chǎn)業(yè)園C區(qū)6號(hào)樓
馮超
0512-65883432
蘇州大學(xué)轉(zhuǎn)化醫(yī)學(xué)研究院
江蘇省蘇州市工業(yè)園區(qū)仁愛路199號(hào)
贊助和大會(huì)咨詢：
湯海榮
E-mail：hairong.tang@bioon.com
Mt ：13524820860
參會(huì)和媒體合作：
何春幸
E-mail：chunxing.he@medsci.cn
M t ：17321098232
通過 TIMEDOO參會(huì)報(bào)名
或點(diǎn)擊鏈接報(bào)名http://timedoo2018.mikecrm.com/XxA01e2
本文系作者 @TIMEDOO 原創(chuàng)發(fā)布在 肽度TIMEDOO。未經(jīng)許可，禁止轉(zhuǎn)載。
